SCHEMBL316764

SCHEMBL316764

CC(C)(C)c1cc(Cc2cc(C(C)(C)C)cc(C(C)(C)C)c2P(=O)(O)O)c(P(=O)(O)O)c(C(C)(C)C)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 5/20 0.36
HSPA5 P11021 2/20 0.36
NR5A2 O00482 1/20 0.35
NR5A1 Q13285 1/20 0.35
CYP2C9 P11712 4/20 0.35
HIF1A Q16665 3/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
HTT P42858 2/20 0.33
NPSR1 Q6W5P4 2/20 0.33
ALDH1A1 P00352 1/20 0.33
GAA P10253 1/20 0.33
XBP1 P17861 1/20 0.33
MAPK1 P28482 1/20 0.33
HMGCR P04035 2/20 0.33
GABRA1 P14867 1/20 0.32
GABRB2 P47870 1/20 0.32
CYP1A2 P05177 2/20 0.32
CYP3A4 P08684 1/20 0.32
TSHR P16473 1/20 0.32
CYP2D6 P10635 3/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2470962 0.84
SCHEMBL945606 0.81 NR5A2 (0.32) CYP2C19HSPA5NR5A2NR5A1CYP2C9
Phosphoric Acid SCHEMBL537656 0.79 HSPA5 (0.56) CYP2C19HSPA5NR5A2NR5A1CYP2C9
SCHEMBL2334329 0.76 INPPL1 (0.36) CYP2C19HSPA5NR5A2NR5A1CYP2C9
SCHEMBL29612109 0.76 INPPL1 (0.36) CYP2C19HSPA5NR5A2NR5A1CYP2C9
SCHEMBL35073 0.74 INPPL1 (0.35) CYP2C19HSPA5NR5A2NR5A1CYP2C9
SCHEMBL20299525 0.74 INPPL1 (0.35) CYP2C19HSPA5NR5A2NR5A1CYP2C9
SCHEMBL20299554 0.74 INPPL1 (0.35) CYP2C19HSPA5NR5A2NR5A1CYP2C9
SCHEMBL888647 0.74 INPPL1 (0.35) CYP2C19HSPA5NR5A2NR5A1CYP2C9
SCHEMBL9660044 0.74 INPPL1 (0.35) CYP2C19HSPA5NR5A2NR5A1CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 118 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3932906-B1 NOVEL COMPOUND, COMPOSITION CONTAINING SAID COMPOUND, AND CURED OBJECT ADEKA CORP (JP) 2023-07-12 EP disclosed
US-11667609-B2 Compound, composition containing said compound, self-healing material, surface coating agent, paint, adhesive, material for battery and cured product ADEKA CORPORATION (JP) 2023-06-06 US disclosed
US-11634545-B2 Layered-substance-containing solution and method of manufacturing same ADEKA CORPORATION (JP) 2023-04-25 US disclosed
US-11618742-B2 Radical polymerization initiator, composition containing same, cured product of composition, production method for cured product, and compound ADEKA CORPORATION (JP) 2023-04-04 US disclosed
US-11591308-B2 2023-02-28 US disclosed
US-20220153698-A1 NOVEL COMPOUND, COMPOSITION CONTAINING SAID COMPOUND, SELF-HEALING MATERIAL, SURFACE COATING AGENT, PAINT, ADHESIVE, MATERIAL FOR BATTERY AND CURED PRODUCT ADEKA CORPORATION (JP) 2022-05-19 US disclosed
EP-3932906-A1 NOVEL COMPOUND, COMPOSITION CONTAINING SAID COMPOUND, AND CURED OBJECT ADEKA CORPORATION (JP) 2022-01-05 EP disclosed
US-20210107887-A1 RADICAL POLYMERIZATION INITIATOR, COMPOSITION CONTAINING SAME, CURED PRODUCT OF COMPOSITION, PRODUCTION METHOD FOR CURED PRODUCT, AND COMPOUND ADEKA CORPORATION (JP) 2021-04-15 US disclosed
US-10946360-B2 Layered-substance-containing solution and method of manufacturing same ADEKA CORPORATION (JP) 2021-03-16 US disclosed
EP-3753958-A1 RADICAL POLYMERIZATION INITIATOR, COMPOSITION CONTAINING SAME, CURED PRODUCT OF COMPOSITION, PRODUCTION METHOD FOR CURED PRODUCT, AND COMPOUND ADEKA CORPORATION (JP) 2020-12-23 EP disclosed
EP-0756943-B1 Heat sensitive recording material NEW OJI PAPER CO LTD (JP) 1999-12-22 EP disclosed
US-5935900-A BENZOTRIAZOLE COMPOUND, DIPHENYLSULFONE ELECTRON ACCEPTOR OJL PAPER CO., LTD. (JP) 1999-08-10 US disclosed
US-5753588-A COMPRISING INDOLYLDIAZAPHTHALIDE BASIC DYE, DIPHENYL SULFONE OR BENZANILIDE DERIVATIVE COLOR ACCEPTOR NEW OJI PAPER COMPANY LIMITED (JP) 1998-05-19 US disclosed
EP-0826511-A1 Heat sensitive recording material Oji Paper Co., Ltd. (JP) 1998-03-04 EP disclosed
EP-0798127-A1 Heat sensitive recording material and method of using it Oji Paper Co., Ltd. (JP) 1997-10-01 EP disclosed
EP-0756943-A1 Heat sensitive recording material NEW OJI PAPER CO., LTD. (JP) 1997-02-05 EP disclosed
US-5565402-A RECORDING LAYER CONTAINING BLACK-FORMING FLUORAN DERIVATIVE AS BASIC DYE, PHENOTHIAZINE DERIVATIVE, DIPHENYL SULFONE DERIVATIVE COLOR ACCEPTOR NEW OJI PAPER CO., LTD. (JP) 1996-10-15 US disclosed
EP-0464502-B1 Heat-sensitive recording material ASAHI DENKA KOGYO KK (JP) 1994-02-16 EP disclosed
US-5175138-A Containing organic phosphate ASAHI DENKA KOGYO KABUSHIKI KAISHA (JP) 1992-12-29 US disclosed
EP-0464502-A1 Heat-sensitive recording material ASAHI DENKA KOGYO KABUSHIKI KAISHA (JP) 1992-01-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11591308-B2 RER1, CBR1, H1-10 CYP2C19 4038/4885HSPA5 3002/4885NR5A2 2291/4885
US-11618742-B2 Radical polymerization initiator, composition containing same, cured product of composition, production method for cured product, and compound ASH2L, RER1, BOLA2; BOLA2B CYP2C19 3638/4885HSPA5 3069/4885NR5A2 2590/4885
US-11667609-B2 Compound, composition containing said compound, self-healing material, surface coating agent, paint, adhesive, material for battery and cured product H1-0, H1-10, RAD51 CYP2C19 1984/4885HSPA5 4333/4885NR5A2 2372/4885
US-20220153698-A1 NOVEL COMPOUND, COMPOSITION CONTAINING SAID COMPOUND, SELF-HEALING MATERIAL, SURFACE COATING AGENT, PAINT, ADHESIVE, MATERIAL FOR BATTERY AND CURED PRODUCT H1-0, H1-10, RAD51 CYP2C19 2088/4885HSPA5 4136/4885NR5A2 2353/4885
US-20210107887-A1 RADICAL POLYMERIZATION INITIATOR, COMPOSITION CONTAINING SAME, CURED PRODUCT OF COMPOSITION, PRODUCTION METHOD FOR CURED PRODUCT, AND COMPOUND RRP12, ASH2L, RER1 CYP2C19 3462/4885HSPA5 3436/4885NR5A2 1431/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.